circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1-Reference-Cited by-同舟云学术

circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1

Published:2021-07-01 Issue:3 Volume:22 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Liang Hongguang¹,Lin Zelong²,Lin Huiwen¹,Zhao Li¹,Huang Weihua¹

Affiliation:

1. Department of Oncology, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510168, P.R. China

2. Department of Thoracic Surgery, Traditional Chinese Medicine‑Integrated Hospital, Southern Medical University, Guangzhou, Guangdong 510315, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNAs in lung cancer: implications for preventing therapeutic resistance;eBioMedicine;2024-09

2. The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer;Cancer Drug Resistance;2024-08-19

3. circPTP4A2 knockdown suppresses NSCLC progression via regulating proliferation and activating anti-tumor immunity;Journal of Cardiothoracic Surgery;2024-07-16

4. Hsa_circ_0022383 promote non-small cell lung cancer tumorigenesis through regulating the miR-495-3p/KPNA2 axis;Cancer Cell International;2023-11-19

5. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non‐small cell lung cancer via positively modulating KPNA4 by sponging miR‐1298‐5p;Thoracic Cancer;2023-07-16